Benicar Victims Must Act by Aug.23 to be Included in $300M Settlement
Daiichi Sankyo on Tuesday said it has agreed to pay up to $300 million to settle some 2,300 U.S. cases accusing the Japanese drugmaker of failing to warn that its blood pressure medication Benicar can cause gastrointestinal illness.
The FDA had previously warned health professionals and consumers that olmesartan medoxomil (the generic name for Benicar, Benicar HCT, Azor and Tribenzor) could cause intestinal problems known as sprue-like enteropathy. These warnings come after several Mayo Clinic studies linked olmesartan use to symptoms that resembled celiac disease. According to the FDA, Spruelike Enteropathy develops months to years after starting olmesartan and sometimes required hospitalization. Originally the drug labels did not warn against these side effects.
Daiichi Sankyo said it was not admitting liability by settling and that it continues to believe that the Benicar claims were without merit.
The lawsuits allege that Daiichi Sankyo:
Brought to market products that cause serious gastrointestinal injuries
Inadequately warned about the risk of gastrointestinal injury from Benicar, Benicar HCT, Azor, and Tribenzor
Misrepresented the safety of olmesartan products, despite knowing (or having enough information to know) that it and similar drugs are unsafe when used as directed
Designed defective, unsafe, and inherently dangerous pharmaceutical products
Did not adequately test drug and similar drugs
Failed in its duty to create safe products
Created products that cause harm that far outweighs their benefit
Valued profits over the safety and wellbeing of patients
Caused patient harm and financial losses as a result of these acts and omissions
The first lawsuits over the drug were filed in 2014 and the cases were eventually consolidated in a multidistrict litigation in federal court in New Jersey.
How The Carlson Law Firm Can Help
The Carlson Law Firm maintains a team of professionals that includes more than 40 experienced lawyers, over 100 qualified and passionate staff, as well as full-time registered nurses and three investigators.
If you, or someone you love was given this medication, and is experiencing Spruelike Enteropathy symptoms, you may be eligible for compensation. Contact an attorney at The Carlson Law Firm today to discuss your options.